For Families Managing a Parent's Care
Often the person who calls is not the patient. It is a son or daughter — coordinating appointments between work and their own family, holding a medication list nobody has reviewed in a year, and carrying the quiet fear of the next 2 a.m. phone call.
Dr. Wechsler's practice is built for that situation. Families are included in planning conversations, reachable directly, and given a clear picture of what is happening and what comes next — so decisions are made deliberately rather than in a hospital corridor.
Built for the people who carry the worry
Included in planning conversations
Family members are welcomed into appointments and care discussions — not as bystanders, but as participants who need to understand what is happening and why.
A direct line, not a phone tree
Families can reach the practice directly. There is no voicemail maze between a worried son or daughter and an answer.
A clear picture of what comes next
Every significant decision — dialysis planning, specialist referrals, changes in medication — is explained in plain language, with time to ask questions.
Continuity through hospitalizations
When a parent is admitted to Hoag Hospital, Dr. Wechsler is there. Families are not left waiting for a hospitalist they have never met to call with updates.
"Decisions made deliberately rather than in a hospital corridor."
Because Kidney Disease Runs in Families
Advanced kidney disease is rarely bad luck alone. Much of it is inherited — through genes, through shared risk factors like diabetes and high blood pressure, and usually both. A first-degree relative of someone with kidney failure carries roughly three times the risk of developing serious kidney disease themselves. Most never know it, because early kidney disease is silent: it causes no symptoms until well over half of kidney function is already lost.
That silent window is exactly where we work. While we care for your parent, we can also look after the people around them — you, your siblings, your children — before disease has a chance to declare itself.
Early detection, done properly. A meaningful kidney evaluation is more than a single creatinine on a routine panel. It includes urine albumin testing (the earliest and most overlooked marker of kidney injury), cystatin C–based kidney function, careful blood-pressure and metabolic profiling, and, where family history warrants it, genetic and inherited-disease screening for conditions such as polycystic kidney disease and APOL1-associated risk.
Intervention that changes the trajectory. The last decade has transformed what we can do once risk is found. Blood-pressure optimization, SGLT2 inhibitors, GLP-1 therapies, and newer agents like finerenone can now meaningfully slow — and in earlier stages, help prevent — the progression that used to be considered inevitable. Started early, in the right person, these tools change outcomes. Started late, they salvage what is left.
This is longevity medicine applied where it matters most. For families who have watched kidney disease up close, this is the chance to change the story for the next generation — proactive, personalized, and grounded in evidence rather than fear.